RhumbLine Advisers
HIMS icon

RhumbLine Advisers’s Hims & Hers Health HIMS Stock Holding History

RhumbLine Advisers’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.8M Sell
631,254
-2,524
-0.4% -$77.5K 0.01% 757
2026
Q2 		$22M Sell
633,778
-10,078
-2% -$271K 0.02% 706
2026
Q1 		$13.4M Buy
643,856
+11,503
+2% +$272K 0.01% 922
2025
Q4 		$20.5M Sell
632,353
-36,942
-6% -$1.58M 0.02% 701
2025
Q3 		$38M Buy
669,295
+4,739
+0.7% +$243K 0.03% 468
2025
Q2 		$33.1M Buy
664,556
+67,225
+11% +$3.04M 0.03% 502
2025
Q1 		$17.7M Buy
597,331
+81,107
+16% +$3.01M 0.02% 749
2024
Q4 		$12.5M Buy
516,224
+249,854
+94% +$6.19M 0.01% 954
2024
Q3 		$4.91M Sell
266,370
-2,050
-0.8% -$36.7K ﹤0.01% 1438
2024
Q2 		$5.42M Buy
268,420
+89,535
+50% +$1.49M 0.01% 1354
2024
Q1 		$2.77M Buy
178,885
+1,896
+1% +$21.4K ﹤0.01% 1743
2023
Q4 		$1.58M Sell
176,989
-7,865
-4% -$58.1K ﹤0.01% 2028
2023
Q3 		$1.16M Sell
184,854
-30,641
-14% -$228K ﹤0.01% 2122
2023
Q2 		$2.03M Buy
215,495
+36,064
+20% +$358K ﹤0.01% 1900
2023
Q1 		$1.78M Buy
179,431
+3,214
+2% +$28.2K ﹤0.01% 1867
2022
Q4 		$1.13M Buy
176,217
+2,855
+2% +$16.3K ﹤0.01% 2065
2022
Q3 		$967K Buy
173,362
+20,161
+13% +$121K ﹤0.01% 2149
2022
Q2 		$694K Buy
+153,201
New +$653K ﹤0.01% 2326

Other funds holding HIMS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

RhumbLine Advisers's HIMS Position: Q3 2026 in Review

RhumbLine Advisers reduced its Hims & Hers Health (HIMS) stake by 0.4% in Q3 2026, selling an estimated $77.5K and leaving 631,254 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #757.

RhumbLine Advisers first reported a position in HIMS in Q2 2022 and has held it in 18 quarters since. The position peaked at $38M in Q3 2025. 378 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • RhumbLine Advisers held 631,254 shares of Hims & Hers Health worth $18.8M as of Q3 2026.
  • RhumbLine Advisers sold 2,524 Hims & Hers Health shares in Q3 2026, an estimated $77.5K.
  • Hims & Hers Health made up 0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #757 holding.
  • RhumbLine Advisers first reported a position in Hims & Hers Health in Q2 2022 and has held it in 18 quarters since.
  • RhumbLine Advisers's Hims & Hers Health position peaked at $38M in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.